Impact of Acetaminophen on Performance of Guardian™ Sensor (3) in Adults
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 104 participants.
Also called NCT04378114
- Study
- In this atlas
Overview
- Design
- Interventional study; non-randomized; no masking; primary purpose other
- Phase
- Not applicable
- Enrolled
- 104 participants
- Sponsor
- Registry
-
NCT04378114
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT04378114. Non-randomized; no masking; primary purpose other. Start 2020-05-18 (actual); primary completion 2020-07-17 (actual). Results posted on 2023-09-08.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Impact of Acetaminophen on Performance of Guardian™ Sensor (3) in Adults
- Condition
- Type 1 Diabetes Mellitus
- Condition
- Type 2 Diabetes Mellitus
- Intervention (Device)
- Guardian™ Sensor (3) connected to a Guardian™ Connect Transmitter. C sensor algorithm applied retrospectively to raw sensor data.
- Intervention (Device)
- Guardian™ Sensor (3) connected to a Guardian™ Connect Transmitter. Zeus sensor algorithm applied retrospectively to raw sensor data.
- Intervention (Drug)
- Acetominophen
- Lead sponsor
- Medtronic MiniMed, Inc.
Record details
- Record id
cardio:ct-nct04378114- Content hash
492731254d5469b0133619b4070b431b67e7310c145a3a67604ebbc2d5e54405